Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
Sodium:solute symporter (SSS) | ||||||
Sodium/glucose cotransporter 2 (SGLT2) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Inhibition (Phlorizin) of SLC5A2 | |||||
Induced Change | Methyl beta-D-glucopyranoside concentration: decrease (FC = 20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Type 2 diabetes mellitus [ICD-11: 5A11] | |||||
Details | It is reported that inhibition of SLC5A2 leads to the decrease of methyl beta-D-glucopyranoside levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of SLC5A2 | |||||
Induced Change | Methyl beta-D-glucopyranoside concentration: increase (FC = 3) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Type 2 diabetes mellitus [ICD-11: 5A11] | |||||
Details | It is reported that overexpression of SLC5A2 leads to the increase of methyl beta-D-glucopyranoside levels compared with control group. | |||||
Sugar transporter (ST) | ||||||
HepG2 glucose transporter (SLC2A1) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Mutation (Gly286Asp) of SLC2A1 | |||||
Induced Change | Methyl beta-D-glucopyranoside concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hereditary haemolytic anaemia [ICD-11: 3A10] | |||||
Details | It is reported that mutation (Gly286Asp) of SLC2A1 leads to the decrease of methyl beta-D-glucopyranoside levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Mutation (S290A) of SLC2A1 | |||||
Induced Change | Methyl beta-D-glucopyranoside concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hereditary haemolytic anaemia [ICD-11: 3A10] | |||||
Details | It is reported that mutation (S290A) of SLC2A1 leads to the decrease of methyl beta-D-glucopyranoside levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.